Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Di Domenico

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|July 27, 2023
Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention programDeo Mujwara, Jen Kintzle, Paolo Di Domenico, et al.
International Journal of Molecular Sciences|October 14, 2023
The Diagnosis and Management of Cutaneous Metastases from MelanomaCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Dermatology Reports|May 13, 2026
Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn's diseaseCosimo Di Raimondo, Edoardo Mortato, Pier Paolo Di Domenico, et al.
Nutrients|March 13, 2025
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. CohortMałgorzata Ponikowska, Paolo Di Domenico, Alessandro Bolli, et al.
Nature Communications|November 5, 2023
Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessmentsGeorge B Busby, Scott Kulm, Alessandro Bolli, et al.
International Journal of Molecular Sciences|July 13, 2024
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of ViewCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Journal of the American Heart Association|June 14, 2022
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis StudyDeo Mujwara, Geoffrey Henno, Stephen T Vernon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|July 27, 2023
Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention programDeo Mujwara, Jen Kintzle, Paolo Di Domenico, et al.
International Journal of Molecular Sciences|October 14, 2023
The Diagnosis and Management of Cutaneous Metastases from MelanomaCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Dermatology Reports|May 13, 2026
Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn's diseaseCosimo Di Raimondo, Edoardo Mortato, Pier Paolo Di Domenico, et al.
Nutrients|March 13, 2025
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. CohortMałgorzata Ponikowska, Paolo Di Domenico, Alessandro Bolli, et al.
Nature Communications|November 5, 2023
Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessmentsGeorge B Busby, Scott Kulm, Alessandro Bolli, et al.
International Journal of Molecular Sciences|July 13, 2024
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of ViewCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Journal of the American Heart Association|June 14, 2022
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis StudyDeo Mujwara, Geoffrey Henno, Stephen T Vernon, et al.
Pageof 1